This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Autogenomics, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Cornelis Hendrikus Wilhelm Klaassen: Innovator in HPV Detection
Introduction
Cornelis Hendrikus Wilhelm Klaassen is a notable inventor based in Wijchen, Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the detection of the Human Papilloma Virus (HPV). His innovative approach has paved the way for advancements in HPV testing methodologies.
Latest Patents
Klaassen holds a patent for a method of detecting the presence of HPV using a DNA microarray. The patent outlines a systematic approach that includes amplifying and labeling part of the E1 HPV gene, specifically its 3' end. The process involves hybridizing the labeled fragment to a solid support containing microarrays with various HPV-specific capture probes. Following this, uncaptured labeled fragments are removed, and a detectable moiety is identified, indicating the presence of HPV sequence DNA in a sample. Additionally, a test kit for carrying out this detection method is provided.
Career Highlights
Throughout his career, Klaassen has worked with various organizations, including Autogenomics, Inc. and Stichting Ter Bevordering Van De Farmacodynamiek. His experience in these companies has contributed to his expertise in the field of molecular diagnostics and has facilitated the development of his innovative patent.
Collaborations
Klaassen has collaborated with notable colleagues, including Eric Fredericus Bernardus Josephus Mar Thunnissen and Clemens Franciscus Maria Prinsen. These collaborations have likely enriched his work and contributed to advancements in HPV detection technologies.
Conclusion
Cornelis Hendrikus Wilhelm Klaassen's contributions to HPV detection represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts have the potential to improve testing accuracy and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
